1. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. Issue 1 (January 2017) Authors: De Visschere, P.; Lumen, N.; Ost, P.; Decaestecker, K.; Pattyn, E.; Villeirs, G. Journal: Clinical radiology Issue: Volume 72:Issue 1(2017) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0370: Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer (STOMP). (November 2020) Authors: Ost, P.; Reynders, D.; Decaestecker, K.; Fonteyne, V.; Lumen, N.; De Bruycker, A.; Lambert, B.; Delrue, L.; Bultijnck, R.; Goetghebeur, E.; Villeirs, G.; De Man, K.; Ameye, F.; Billiet, I.; Joniau, S.; Vanhaverbeke, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SP-0105: The role of MRI in active surveillance. (April 2016) Authors: Villeirs, G. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗